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Abstract 
BACKGROUND: Diabetes mellitus (DM) is a major health problem globally. There are many studies, which show 
high prevalence of thyroid disorders in patients with type 2 DM. The aim of this study was to investigate the 
prevalence of thyroid dysfunction in patients with type 2 DM. 
METHODS: 90 patients with type 2 DM aged between 40-70 years were studied. Following a detailed history, all 
patients were evaluated for thyroid dysfunction by testing thyroid-stimulating hormone (TSH), free triiodothyronine 
(FT3), free thyroxine (FT4). The prevalence of thyroid dysfunction and its correlation with age, gender, hemoglobin 
A1c (HbA1c), and duration of DM were studied. 
RESULTS: Out of 90 patients studied, 16 were found to have thyroid dysfunction. The most common thyroid abnormality 
was subclinical hypothyroidism followed by hypothyroidism; furthermore, thyroid abnormality was seen mostly in patients 
aged more than 60 and in those with uncontrolled DM. 
CONCLUSION: Patients with type 2 DM should be screened for thyroid dysfunction, especially those with poor 
diabetic control. 
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Introduction1 
Type 2 diabetes mellitus (DM) is the most 
common metabolic disorder caused by 
hyperglycemia due to insulin resistance and 
impairment in pancreatic beta cells (β cells) 
function which leads to disturbances in the 
metabolism of carbohydrates, proteins, and 
lipids.1 Prevalence of DM is rapidly growing 
worldwide; in 2000, the estimated prevalence 
of DM was 2.8% and was predicted to rise to 
4.4% by 2030.2 
Thyroid diseases are second common 
endocrine disorder after DM.3 Thyroid 
hormone plays an important role in energy 
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homeostasis and metabolism and contributes 
to glucose regulation and insulin action.4,5 
Prevalence of thyroid diseases is more 
common in patients with DM than general 
population and hypothyroidism was 
frequently encountered in patients with type 2 
DM.6,7 The association between them has been 
reported and it has been shown to influence 
each other. Since both thyroid hormones and 
insulin are widely involved in cellular 
metabolism, therefore, excess or deficiency of 
each of them may contribute to disruption of 
the function of the other hormone.8 
Presence of thyroid dysfunction in patients 
with DM has been proven to worsen 
microvascular and macrovascular 
complications of DM and increase overall 
morbidity and mortality; thus, diagnosing 
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help clinicians optimize metabolic control and 
reduce DM-related complications.9 
The association of thyroid dysfunction in 
patients with DM is widely studied by 
researchers across the world; while until 
recently, no such study is conducted in 
Kurdistan, Iraq. The present study was 
designed to establish the prevalence and 
characteristics of thyroid disorders in 
individuals with type 2 DM. 
Materials and Methods 
This cross-sectional study was carried out at 
Ble General Hospital in Erbil City, Iraq. A 
sample of 90 patients who had type 2 DM with 
their age between 40-70 years were selected 
using convenience method of sampling. Those 
patients with type 1 DM or known history of 
thyroid dysfunction, those who were pregnant 
or were on medications affecting thyroid 
function such as amiodarone, lithium, steroids, 
and those with history of neck irradiation were 
excluded from the study. Data were collected 
and recorded using a specially-designed 
questionnaire after getting an informed 
consent from the patients. 
A detailed history focusing on duration and 
onset of DM, comorbidities, history of thyroid 
disease, neck irradiation, and treatment for DM 
was taken; then, a thorough physical 
examination was performed. Later on, all 
patients were sent for laboratory tests including 
lipid profile, hemoglobin A1c (HbA1C), and 
thyroid function test [thyroid stimulating 
hormone (TSH), free triiodothyronine (FT3), 
free thyroxine (FT4)]. Thyroid hormone levels 
were measured by chemiluminescence 
immunoassay (CLIA) using VIDAS machine 
(bioMérieux Inc., France). Normal values of 
thyroid hormones using this test were as  
TSH between 0.4-4.2 mIU/ml, FT4 between 
10.30-23.17 pmol/l, and FT3 ranging between 
2.2-4.2 pg/ml. According to this test, the 
patients were categorized into four groups of 
thyroid dysfunction as Subclinical 
hypothyroidism (defined as high serum level of 
TSH and normal FT4 and FT3 levels), overt 
hypothyroidism (described as high level of TSH 
coupled with low FT4 and FT3 levels), 
subclinical hyperthyroidism (defined as 
decreased level of TSH and high FT4 and FT3 
levels), and hyperthyroidism (low TSH level 
and high FT4 and FT3 levels). 
The data were managed by Microsoft Excel 
(version 2016) using chi-square test and 
Fisher’s exact test. A P-value less than 0.050 
was considered statistically significant. 
Results 
In the present study, 90 patients with type 2 
DM were screened for thyroid abnormality. 46 
patients were female and 44 patients were 
male. Age of the patients ranged between 40 to 
70 years. In this study, 82.3% of the patients 
had normal thyroid function, 11.1% had 
subclinical hypothyroidism, and 3.3% had 
overt hypothyroidism. Hyperthyroid patients 
were 2.2% and just 1.1% of patients were 
revealed to have subclinical hyperthyroidism. 
This is shown in table 1.  
 
Table 1. Frequency and percentage of patients 
with diabetes with thyroid dysfunction 
Thyroid dysfunction n (%) 
Normal thyroid function 74 (82.3) 
Subclinical hypothyroidism 10 (11.1) 
Hypothyroidism 3 (3.3) 
Subclinical hyperthyroidism 1 (1.1) 
Hyperthyroidism 2 (2.2) 
Total 90(100) 
 
Among all patients who had DM, 25 ones 
aged between 40-50 years, 34 patients were 
between 50-60 years, and 31 patients were 
more than age of 60. Majority of the patients 
who had thyroid dysfunction were more than 
the age of 60 (68.8%); this is in contrast to those 
patients with DM without thyroid dysfunction 
in whom just 27.0% fell in this group. 18.8% of 
patients were between the age of 50-60 years 
and just 12.5% were below the age of 50 years. 
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Table 2. The association of age and sex with thyroid dysfunction in patients with diabetes 
Variable Age group (year) Sex 
 40-50 50-60 > 60 P Male Female P 
Thyroid dysfunction (n = 25) (n = 34) (n = 31) (n = 44) (n = 46) 
Present (n = 16) 2 (12.5) 3 (18.8) 11 (68.8) 0.022 7 (43.8) 9 (56.3) 0.655 
Absent (n = 74) 23 (31.1) 31 (41.9) 20 (27.0) 37 (50.0) 37 (50.0) 
Amounts are presented as frequency (Percent). 
 
not have thyroid dysfunction, 41.9% were 
between the age of 50-60 years and 31.1% were 
between 40-50 years of age. Fisher’s exact test 
revealed a significant association between the 
age and presence of thyroid dysfunction in 
patients with DM (P = 0.022). 
In the current study, 56.3% of the patients 
with thyroid dysfunction were female and 
43.8% were male. This is in comparison to those 
patients without thyroid dysfunction in whom 
50.0% were male and 50.0% were female. These 
differences were not statistically significant  
(P = 0.655). This information is shown in table 2. 
Using HbA1c as an index for categorization 
of the patients with DM, it was revealed that 
100% of patients with thyroid dysfunction had 
HbA1c of ≥ 6.5% and 91.1% of the patients 
without thyroid problem had HbA1c ≥ 6.5%. 
There was no significant association between 
HbA1c and thyroid dysfunction (P = 0.179). 
According to duration of DM, the patients 
were divided into four groups of > 10, 6-10, 1-5, 
and ≤ 1 year, and the percentages of thyroid 
dysfunction in these groups were 18.8%, 56.3%, 
18.8%, and 6.3%, respectively. On the other 
hand, in those without thyroid dysfunction, the 
percentages were 27.0%, 24.3%, 23.0%, and 
25.7%, respectively. There was no significant 
association between duration of DM and 
presence of thyroid dysfunction (P = 0.419) as is 
shown in table 3. 
Discussion 
In this study, 90 patients with type 2 DM were 
screened for thyroid dysfunction. Of them, 16 
patients (17.7%) had thyroid dysfunction; 
remaining 74 patients (82.3%) were euthyroid. 
These findings are consistent with studies of 
Khurana et al.8 which revealed overall 
prevalence of thyroid dysfunction of 16.0% 
and Papazafiropoulou et al.10 which showed 
the prevalence rate of 12.3% among patients 
with DM. Another study indicated that thyroid 
dysfunction was present in 16.0% of Saudi 
patients with type 2 DM.11 Similarly, a study 
from Jordan reported the overall prevalence of 
thyroid disease in 12.5% of patients.12  
Subclinical hypothyroidism was the most 
common thyroid abnormality reported in 
11.1% of patients followed by hypothyroidism 
which was seen in 3.3%; hyperthyroidism and 
subclinical hyperthyroidism were seen in 2.2% 
and 1.1% of patients, respectively. These 
findings were in line with results of Perros et 
al.,11 Khurana et al.,8 Radaideh et al.,12 and 
Centeno Maxzud et al.13 
In this study, no significant difference was 
observed in prevalence of thyroid dysfunction 
between male and female subjects; these 
findings are in contrast with several studies 
which showed higher prevalence of thyroid 
dysfunction in female patients.8,11,14 
  
Table 3. Association of hemoglobin A1c (HbA1c) and duration of diabetes with thyroid dysfunction  
in patients with diabetes 
Variable HbA1c Group  Duration of Diabetes (year) 
 < 6.5% ≥ 6.5% P ≤ 1 1-5 6-10 > 10 P 
Thyroid dysfunction (n = 6) (n = 84) (n = 20) (n = 20) (n = 27) (n = 23) 
Present (n = 16) 0 (0) 16 (100) 0.179 1 (6.3) 3 (18.8) 9 (56.3) 3 (18.8) 0.419 
Absent (n = 74) 6 (8.1) 68 (91.9) 19 (25.7) 17 (23.0) 18 (24.3) 20 (27.0) 
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All patients with thyroid abnormality had 
HbA1C value greater than 7.0%. Moreover, 
this study demonstrated high prevalence of 
thyroid abnormality in subjects older than 60 
years of age which was assumed significant 
statistically (P = 0.022). A study done by Jali et 
al. also reported increasing prevalence of 
thyroid dysfunction with advancing of age.15 
This study could not establish significant 
association between duration of DM and 
thyroid abnormality. 
Conclusion 
There is a high prevalence of thyroid 
dysfunction in patients with type 2 DM. 
Subclinical hypothyroidism followed by 
hypothyroidism was the most common 
abnormality; the incidence is higher in elderly 
patients and in patients with uncontrolled DM. 
Thus, it is advised to do regular screening of 
patients with type 2 DM for potential thyroid 
abnormality. 
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